Changes in Gastric Pathology after H. pylori Treatment in Community-Driven Research Aimed at Gastric Cancer Prevention
- PMID: 37568765
- PMCID: PMC10417032
- DOI: 10.3390/cancers15153950
Changes in Gastric Pathology after H. pylori Treatment in Community-Driven Research Aimed at Gastric Cancer Prevention
Abstract
Community-driven projects have characterized Helicobacter pylori (Hp) infection in Indigenous communities in the Northwest Territories (NT) and Yukon (YT), Canada. These projects address concerns about the frequent diagnosis of Hp infection among community members and its relation to gastric cancer deaths, perceived to occur with alarming frequency in this region. Projects included breath-test screening for Hp infection, gastroscopy with gastric biopsies, and treatment to eliminate Hp infection. Previous project results showed a high prevalence of stomach pathologies associated with increased cancer risk among Hp-positive participants at baseline. This analysis describes changes in precancerous gastric pathologies in project participants who had gastroscopy before baseline treatment during 2008-2013 and again in 2017. Throughout the study period, the same pathologist graded Hp density, active gastritis, chronic gastritis, atrophic gastritis, and intestinal metaplasia using the updated Sydney System. Of 310 participants from three communities with baseline pathology data, 69 had follow-up pathology data. Relative to baseline, the prevalence of Hp infection and precancerous gastric pathology was substantially lower at follow-up; most participants who were Hp-positive at baseline and Hp-negative at follow-up had reduced severity of active, chronic, and/or atrophic gastritis at follow-up. Though follow-up numbers are small, these results yield evidence that successful Hp treatment has the potential to reduce the risk of gastric cancer in Arctic Indigenous communities.
Keywords: Arctic; Canada; Helicobacter pylori; active gastritis; atrophic gastritis; chronic gastritis; gastric cancer; gastritis; indigenous health; intestinal metaplasia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Burden of disease from Helicobacter pylori infection in western Canadian Arctic communities.BMC Public Health. 2019 Jun 11;19(1):730. doi: 10.1186/s12889-019-7065-x. BMC Public Health. 2019. PMID: 31185961 Free PMC article.
-
[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. doi: 10.1590/s0004-28032007000200002. Arq Gastroenterol. 2007. PMID: 17962851 Portuguese.
-
[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].Pol Merkur Lekarski. 2008 Feb;24(140):95-100. Pol Merkur Lekarski. 2008. PMID: 18634262 Polish.
-
Treatment of Helicobacter pylori infection in atrophic gastritis.World J Gastroenterol. 2018 Jun 14;24(22):2373-2380. doi: 10.3748/wjg.v24.i22.2373. World J Gastroenterol. 2018. PMID: 29904244 Free PMC article. Review.
-
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26. Gastroenterology. 2021. PMID: 34454714 Free PMC article. Review.
References
-
- Goodman K.J., Correa P., Tengana Aux H.J., Ramirez H., DeLany J.P., Guerrero Pepinosa O., Lopez Quiñones M., Collazos Parra T. Helicobacter pylori Infection in the Colombian Andes: A population-based study of transmission pathways. Am. J. Epidemiol. 1996;144:290–299. doi: 10.1093/oxfordjournals.aje.a008924. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous